GlassScriptPhysician profile
Brian K Thwaites
NPI 1154330256
$2,971.86
in general payments reported to CMS, 2019-2025
33 companies · $741 in 2025
The $741 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $386 · 2021: $114 · 2022: $401 · 2023: $382 · 2024: $564 · 2025: $741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,663 · Education: $24.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,662.99 |
| Education | $24.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $697.28 | 2019-2024 | Senza |
| Spr Therapeutics, INC | $290.62 | 2024-2025 | Sprint Pns System |
| Abbott Laboratories | $238.08 | 2019-2024 | Eterna |
| Vertos Medical, INC. | $222.50 | 2022-2024 | Mild Device Kit |
| Boston Scientific Corporation | $210.01 | 2022-2025 | Intracept |
| Collegium Pharmaceutical, INC. | $175.64 | 2023-2025 | Belbuca, Xtampza |
| Relievant Medsystems, INC. | $154.43 | 2020 | |
| Globus Medical, INC. | $139.45 | 2025 | Senza |
| Stryker Corporation | $115.21 | 2025 | Mild Device Kit |
| Vertex Pharmaceuticals Incorporated | $70.30 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $70.04 | 2019-2023 | Bridion |
| Arbor Pharmaceuticals, INC. | $44.31 | 2019 | |
| Valinor Pharma, LLC | $43.60 | 2025 | Movantik |
| Abbvie INC. | $43.23 | 2022 | |
| Scilex Pharmaceuticals INC. | $39.96 | 2020-2023 | Ztlido |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $33.71 | 2023 | Horizant |
| Daiichi Sankyo INC. | $31.82 | 2019 | |
| Edwards Lifesciences Corporation | $30.97 | 2022 | |
| Redhill Biopharma INC. | $30.76 | 2022 | |
| Chiesi USA, INC. | $29.50 | 2021-2022 | |
| Tonix Medicines, INC. | $27.56 | 2025 | Tonmya |
| Curonix LLC | $24.01 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Si-Bone, INC. | $23.83 | 2022 | |
| Pfizer INC. | $23.55 | 2024 | |
| Medtronic, INC. | $23.09 | 2021 | |
| Mdd US Operations, LLC | $21.71 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $20.16 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.99 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.79 | 2019 | |
| Depuy Synthes Sales INC. | $17.31 | 2019 | |
| Biodelivery Sciences International, INC. | $15.02 | 2021 | |
| Zyla Life Sciences, INC. | $14.17 | 2019 | |
| Ge Healthcare | $12.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Thwaites listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.